Cheng Zhuo - Eastern Hepatobiliary Surg Hosp, Naval Med Univ

基本信息

浏览量：12

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 29 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Bortezomib in Previously Treated Phosphatase and Tension Homology‐deficient Patients with Advanced Intrahepatic Cholangiocarcinoma: an Open‐label, Prospective and Single‐centre Phase II Trial

Tian-mei Zeng,Tian-yi Jiang,Guang Yang,Zhuo Cheng,Cheng Lou, Wei,Chen-jie Tao,Shouzi Hu,Hui Wang,Xiao-wen Cui,Ye-xiong Tan,Li-wei Dong,Hong-yang Wang,Zhen-gang Yuan

CLINICAL AND TRANSLATIONAL MEDICINEno. 5 (2024)

引用0浏览0WOS引用

Perioperative Tislelizumab Plus Intensity Modulated Radiotherapy in Resectable Hepatocellular Carcinoma with Macrovascular Invasion: a Phase II Trial

Hongyu Pan, Liuyu Zhou,Zhuo Cheng, Cheng Yang, Jin Zhang,Ningjia Shen, Hongbin Ma, Yao Li,Riming Jin,Weiping Zhou, Dong Wu, Wen Sun,Ruoyu Wang

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0WOSNATURE引用

Superior Survival Benefits of Triple Combination Immunotherapy Compared to Standard Chemotherapy As Second-Line Treatment for Advanced Biliary Tract Cancer: a Retrospective Analysis

Peipei Shang, Heming Xu, Tianmei Zeng,Cheng Lou, Wei,Guang Yang,Zhuo Cheng, Xiaowen Cui, Weipeng Hong, Weidong Shen, Zhengang Yuan

Frontiers in Oncology (2024)

引用0浏览0引用

Efficacy and Predictors of Immune Checkpoint Inhibitors in Patients with Gallbladder Cancer

Zhuo Cheng, Cheng Yang,Qian Zhao, Jingjiao Zhong,Jin Zhang,Riming Jin, Yao Li,Na Ta,Dong Wu,Zhengang Yuan,Wen Sun,Ruoyu Wang

Journal of Clinical Oncologyno. 16_suppl (2023): e16124-e16124

引用0浏览0WOS引用

Clinical and Biomarker Analyses of Sintilimab Plus Gemcitabine and Cisplatin As First-Line Treatment for Patients with Advanced Biliary Tract Cancer

Tian-mei Zeng,Guang Yang,Cheng Lou, Wei,Chen-jie Tao,Xi-yun Chen,Qin Han,Zhuo Cheng,Pei-pei Shang,Yu-long Dong,He-ming Xu,Lie-ping Guo,Dong-sheng Chen,Yun-jie Song,Chuang Qi,Wang-long Deng,Zhen-gang Yuan

Nature communicationsno. 1 (2023): 1340-1340

引用2浏览0WOSNATURE引用

Toripalimab Combined with Anlotinib As the Second-Line Treatment for Advanced Hepatocellular Carcinoma Patients: a Prospective, Single Arm Phase II Clinical Study

Wei,Xiyun Chen,Tianmei Zeng,Guang Yang,Yulong Dong,Chenjie Tao, Qin Han,Cheng Lou,Peipei Shang,Zhuo Cheng,Weipeng Hong,Yuange He, Weidong Shen,Zhengang Yuan,Lieping Guo

crossref（2023）

引用0浏览0引用

Genomic and Immune Features in an Intrahepatic Cholangiocarcinoma Patient with Microsatellite Instability-High Suffered Rapid Acquired Resistance to PD-1 Inhibitor

Zhuo Cheng,Tianmei Zeng,Guang Yang, Di Liu, Zhi Zheng,Zhengang Yuan

Liver cancerno. 3 (2023): 281-288

引用0浏览0WOS引用

Development and Validation of a Machine Learning Model for Differential Diagnosis of Malignant Pleural Effusion Using Routine Laboratory Data

Ting-Ting Wei,Jia-Feng Zhang,Zhuo Cheng,Lei Jiang,Jiang-Yan Li,Lin Zhou

openalex（2023）

引用0浏览0引用

Toripalimab combined with anlotinib as the second-line treatment for advanced hepatocellular carcinoma patients: a prospective, single arm phase II clinical study

Wei Wei,Xiyun Chen,Tianmei Zeng,Guang Yang,Yulong Dong,Chenjie Tao,Qin Han,Cheng Lou,Peipei Shang,Zhuo Cheng,Weipeng Hong, Yan He, Weidong Shen,Zhen-gang Yuan,Lei Guo

Research Square (Research Square) (2023)

引用0浏览0引用

Sintilimab Plus Gemcitabine and Cisplatin As a First-Line Treatment for Patients with Advanced Biliary Tract Cancer: A Biomolecular Exploratory, Phase II Clinical Trial

Zhen-Gang Yuan,Tian-Mei Zeng,Guang Yang,Cheng Lou, Wei,Chen-Jie Tao,Xi-Yun Chen,Qin Han,Zhuo Cheng,Pei-Pei Shang,Yu-Long Dong,He-Ming Xu,Lie-Ping Guo,Dong-Sheng Chen,Yunjie Song,Chuang Qi,Wanglong Deng

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn